The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.

The largest deal announcement of the week was AbbVie Inc.‘s and Genmab A/S’ new broad oncology collaboration valued at $750 million. The two companies are signing a broad collaboration agreement to jointly develop and commercialize three of Genmab’s early-stage investigational bispecific antibody product candidates.

To subscribe to our Health Care M&A deals chart and more, visit our membership siteHealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.

Click here to view our quarterly and annual publications and here to view our monthly webinar series.

Biotechnology    
Acquirer Target Price
CSL Behring Vitaeris Inc. N/A
Sernova Corp. Converge Biotech, Inc N/A
AbbVie Inc. Broad oncology collaboration $750,000,000
Melinta Therapeutics, Inc. Tetraphase Pharmaceuticals, Inc. $39,000,000
Laboratories, MRI and Dialysis    
Acquirer Target Price
RapidAI EndoVantage N/A
Long-Term Care    
Acquirer Target Price
Kayne Anderson Real Estate Advisors The Watermark at Trinity N/A
Best Care Senior Living at St. Pete, LLC Loving Care of St. Petersburg N/A
Elevation Financial Group Kennington Pointe $2,200,000
Pharmaceuticals    
Acquirer Target Price
Mydecine Innovations Group Inc. NeuroPharm Inc. $4,471,705
Physician Medical Groups    
Acquirer Target Price
CRH Medical Corporation Lake Lanier Anesthesia Associates N/A
CRH Medical Corporation Oconee River Anesthesia Associates N/A